Neotigason®

NEOTIGASON is used to treat severe psoriasis (skin disease with thickened patches of red skin, often with silvery scales) and other severe disorders of the skin.

NEOTIGASON belongs to a group of medicines called retinoids, which are very similar to Vitamin A. Vitamin A, which we obtain from food, is important for the normal growth and development of the body, especially the skin.

Important Information before you take Neotigason

Do not take NEOTIGASON if you are pregnant, or intend to become pregnant during treatment or in the 3 years after stopping treatment.

The possibility that you may be pregnant must be ruled out by you and your doctor before you start taking NEOTIGASON. A pregnancy test must be negative when performed within one week before beginning of treatment.

NEOTIGASON is highly teratogenic and there is an extremely high risk that a severely deformed baby will result if taken before or during pregnancy, no matter for how long or at what dose. You must use effective contraception (preferably two complementary forms), without interruption for one month before, during and 3 years after treatment. A combination hormonal contraceptive product or an intrauterine device should be used. It is recommended that a diaphragm is also used. Low dose minipills (progesterone only) are not recommended.

Do not breastfeed while taking NEOTIGASON. Breastfeeding must be stopped before treatment begins. 

For further information please download and read the NEOTIGASON Consumer Medicine Information and the NEOTIGASON Patient Information Leaflet in the links below.

Date of preparation: November 2024, NEOT-AU-NP-00009. Date of expiration: November 2026.